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Dye-labelled DNA sequencing is one of the most common and
robust technique required for molecular biology since 1977 (San-
ger, 1977) [1]. I have recently provided the single-step puriﬁcation
method for dye-labeled sequencing products, which is based on
the removal of the washing step in EDTA/ethanol precipitation
(Fujikura, 2015) [2]. Here I assess and report the accumulated data
of the modiﬁed method on the larger scale in practice.
& 2016 The Author. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Molecular biology
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xperimental
factorsDye-labeled sequencing reaction is performed in speciﬁed dilution rate.ier Inc. This is an open access article under the CC BY license
ED
K. Fujikura / Data in Brief 7 (2016) 873–876874xperimental
featuresThe modiﬁed EDTA/ethanol method skips the washing step in EDTA/ethanol
precipitation for dye-labeled DNA sequencing.ata source
locationJapanata accessibility The data are with this article.D
Value of the data
 The data provide the scheme and characterize the success rate for modiﬁed EDTA/ethanol pur-
iﬁcation method for dye-labeled DNA sequencing.
 The data provide the optimization of methods, including the amount of DNA template, primers,
and buffer conditions for rapid puriﬁcation of dye-labeled sequencing.
 The modiﬁed method provides the quick and inexpensive puriﬁcation technique for DNA
sequencing.1. Data
Dye-labeled DNA sequencing technique is still an important tool for clinical decision making on
cancer [3–5], drug metabolism genotyping [6–8], pathogen identiﬁcation [9–11], inherited disease [12–
17] and so on [18,19]. However, the methods remain laborious and time-consuming. Here I modiﬁed
sequencing method and assessed its data quality (Fig. 1). The modiﬁed method requires only 10 min,
whereas commercial puriﬁcation kits and standard ethanol precipitation require a longer processing
time. DNA sequences of more than 850–900 bp were more stably obtained in a single sequencing
reaction with this rapid method without compromising high-quality base calling and read length
(916735 bp, n¼168, QV420). (Fig. 1). The read length obtained by this method was signiﬁcantly
longer than that obtained by standard methods (modiﬁed EDTA vs. standard EDTA (877737 bp,
n¼168); Po0.01) (Fig. 1). The failure rate of modiﬁed method was quite low (0.6%; 1/168).2. Experimental design, materials and methods
2.1. Sequencing reaction
Sequencing reaction was performed in a 10 μl scale using the BigDye Terminator v3.1 Cycle
Sequencing Kit (dilution rate: 1:16–1:32) (Applied Biosystems, Foster City, CA, USA), 10 pmol of
various primers, and 50–1500 ng of template DNA (50 ng for 100–300 bp PCR product, 250 ng for
300–2000 bp PCR product, or 1500 ng for plasmid) for one experimental run. The following thermal
cycle was used for the ampliﬁcations: 96 °C for 1 min, followed by 40–50 cycles of 96 °C for 10 s, 50–
58 °C for 5 s and 60 °C for 150 s.
2.2. Modiﬁed puriﬁcation technique and data analysis
1 μl of 125 mM of EDTA and 30 μl of 100% ethanol were added to each sequencing reaction, and
the mixture was then lightly vortexed (Fig. 1). After centrifugation (15,000g, 5 min for tube; 4000 g,
15 min for plate), the supernatant was carefully aspirated and discarded. Next, after drying the pre-
cipitate, 40 μl of distilled water or TE0.1 buffer (10 mM Tris–acetate [pH 8.0] þ 0.1 mM EDTA) was
added to each reaction. ABI PRISM 3130 Genetic analyzer and POP-7 polymer were used as the
separation machine and matrices, but the other Genetic analyzer (ABI Prism 310, 3730, or 3500) and
polymers (POP-4 or POP-6) are also applicable. The sequence data was analyzed with ABI Prism DNA
Sequencing Analysis Software v5.1. The quality value score 20 (QV20) was used as indicator of
sequencing quality. Student's t tests were performed to evaluate the signiﬁcance between two
methods.
Fig. 1. (A) Method for the single-step puriﬁcation of dye-labeled sequencing products is described in left half. (B) Comparison
of the sequence read lengths with QV420 in two different methods is shown in right graph. Results are shown as the
means7standard deviations (Student t tests; ∗Po0.01).
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